TNBC encompasses a heterogeneous group of breast cancers with distinct clinical characteristics, transcriptomic and genomic features, and unique histopathological differences marked by the lack of expression of ER, PR, and HER2 (Borri and Granaglia, 2021). This evidence concerns the gene ERBB2 and breast cancer.